Swiss National Bank
CGEM icon

Swiss National Bank’s Cullinan Oncology CGEM Stock Holding History

Swiss National Bank’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.38M Buy
76,000
+17,700
+30% +$263K ﹤0.01% 2101
2026
Q1 		$828K Hold
58,300
– – ﹤0.01% 2202
2025
Q4 		$603K Buy
58,300
+8,000
+16% +$72.2K ﹤0.01% 2269
2025
Q3 		$298K Hold
50,300
– – ﹤0.01% 2315
2025
Q2 		$379K Sell
50,300
-12,400
-20% -$99.6K ﹤0.01% 2324
2025
Q1 		$475K Hold
62,700
– – ﹤0.01% 2344
2024
Q4 		$764K Sell
62,700
-10,900
-15% -$157K ﹤0.01% 2312
2024
Q3 		$1.23M Hold
73,600
– – ﹤0.01% 2119
2024
Q2 		$1.28M Buy
73,600
+27,300
+59% +$581K ﹤0.01% 2047
2024
Q1 		$789K Hold
46,300
– – ﹤0.01% 2329
2023
Q4 		$472K Buy
46,300
+7,700
+20% +$68.2K ﹤0.01% 2485
2023
Q3 		$349K Hold
38,600
– – ﹤0.01% 2569
2023
Q2 		$415K Buy
38,600
+9,000
+30% +$95.6K ﹤0.01% 2566
2023
Q1 		$303K Sell
29,600
-3,400
-10% -$37.5K ﹤0.01% 2605
2022
Q4 		$348K Buy
33,000
+2,100
+7% +$25.5K ﹤0.01% 2635
2022
Q3 		$396K Hold
30,900
– – ﹤0.01% 2629
2022
Q2 		$396K Sell
30,900
-5,300
-15% -$60.1K ﹤0.01% 2665
2022
Q1 		$379K Buy
36,200
+2,700
+8% +$36.5K ﹤0.01% 2635
2021
Q4 		$517K Buy
33,500
+4,900
+17% +$97.7K ﹤0.01% 2658
2021
Q3 		$646K Hold
28,600
– – ﹤0.01% 2540
2021
Q2 		$736K Buy
+28,600
New +$880K ﹤0.01% 2565

Other funds holding CGEM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TFCP
Twin Focus Capital Partners Boston, Massachusetts $983M AUM 37.07% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

Swiss National Bank's CGEM Position: Q2 2026 in Review

Swiss National Bank increased its Cullinan Oncology (CGEM) stake by 30% in Q2 2026, buying an estimated $263K and bringing the position to 76,000 shares worth $1.38M. The position accounts for ﹤0.01% of the portfolio, ranked #2101.

Swiss National Bank first reported a position in CGEM in Q2 2021 and has held it in 21 quarters since. 58 funds tracked by Wall St. Rank hold CGEM as of Q2 2026.

  • Swiss National Bank held 76,000 shares of Cullinan Oncology worth $1.38M as of Q2 2026.
  • Swiss National Bank bought 17,700 Cullinan Oncology shares in Q2 2026, an estimated $263K.
  • Cullinan Oncology made up ﹤0.01% of Swiss National Bank's portfolio in Q2 2026, its #2101 holding.
  • Swiss National Bank first reported a position in Cullinan Oncology in Q2 2021 and has held it in 21 quarters since.
  • 58 funds tracked by Wall St. Rank held Cullinan Oncology as of Q2 2026.

Based on Swiss National Bank's 13F filing for Q2 2026, filed 11 Aug 2026.